Relmada Therapeutics names Cedric O’Gorman MD as Chief Medical Officer

Relmada Therapeutics announced the appointment of Cedric O’Gorman MD as the company’s Chief Medical Officer. Dr. O’Gorman will lead medical, clinical and regulatory functions in support of the company’s late-stage REL-1017 development program. Dr. O’Gorman brings to Relmada more than two decades of life sciences experience in clinical development, medical affairs and medical strategy, with significant expertise in the CNS therapeutics field. Most recently, he served as Chief Medical Officer at Alpha Cognition, where he led clinical development programs for the company’s Alzheimer’s disease targets.